Sullivan & Worcester represented Chromocell Therapeutics Corporation, while Manatt, Phelps & Phillips represented A.G.P./ Alliance Global Partners in the transaction. Chromocell Therapeutics Corporation executed their $6.6...
Chromocell Therapeutics Corporation’s $6.6 Million Initial Public Offering
TPG Growth’s $228 Million Investment in Sayari
Kirkland & Ellis advised TPG Growth in its transaction and Manatt, Phelps & Phillips advised Sayari Labs, Inc.. TPG Growth (Nasdaq: TPG), TPG’s middle-market and growth...
ZyVersa Therapeutics’ Merger With Larkspur Health Acquisition Corp.
Lowenstein represented ZyVersa Therapeutics in the transaction, while Alston & Bird advised Larkspur Health Acquisition Corp. Manatt, Phelps & Phillips advised A.G.P./Alliance Global Partners. ZyVersa Therapeutics,...
Relativity Acquisition Corp.’s $143.75 Million IPO
Manatt Represented A.G.P. and Brookline Capital Markets in Relativity Acquisition Corp.’s $143.75M IPO. Relativity Acquisition Corp., a special purpose acquisition company (SPAC), offered 14,375,000 units at $10.00...